Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
03/19/2003 | EP0556333B1 Avirulent salmonella microbes comprising a mutation in the cdt gene and uses therefor |
03/19/2003 | CN1404528A Transgenic cells expressing glucosyltransferase nucleic acids |
03/19/2003 | CN1404488A NOGO receptor-mediated blockade of axonal growth |
03/19/2003 | CN1404484A Pluraflavins and derivatives thereof, process for their preparation and use thereof |
03/19/2003 | CN1404401A G-CSF conjugates |
03/19/2003 | CN1403578A Combined multi-strain liquid state fermentation process of preparing hydrogen |
03/19/2003 | CN1403570A Nikemycin Z component engineering bacterium and its application |
03/19/2003 | CN1403569A In vivo established strain of genetic recombined inteferon and its use |
03/19/2003 | CN1403568A Fluorescent pseudomonad, bacillus prepn for preserving fruits and vegetables and its production process |
03/19/2003 | CN1403567A Prepn process of live lactic and butyric acid bucillus product |
03/19/2003 | CN1403566A Phellinus igniarius sporophore product and its producing process and use |
03/19/2003 | CN1403565A Fermentation process of producing agaric and its culture medium |
03/19/2003 | CN1103369C Bacillus preparation and its preparing process and use |
03/18/2003 | US6534643 Isolated nucleic acid of given sequence; useful for homology-dependent pairing of three DNA strands; use in cloning and gene mapping |
03/18/2003 | US6534641 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease. |
03/18/2003 | US6534485 Novel human protein called Bone Marrow-Specific Protein (BMSP), and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein. |
03/18/2003 | US6534477 Production and use of modified cystatins |
03/18/2003 | US6534476 Smad6 and uses thereof |
03/18/2003 | US6534315 Yeast transformation cassette |
03/18/2003 | US6534309 Motor proteins and methods for their use |
03/18/2003 | US6534305 Aerobic fermentation of preferential substances; obtain culture apparatus, dispersing and supplying air, oxygen, or a mixed gas of ammonia to culture through pipe, recover preferential substances |
03/18/2003 | US6534304 Novel lactic acid bacteria of Lactobacillus helveticus that produce particular tripeptide with high efficiency when cultured in animal milk medium and have high extracellular proteinase activity |
03/18/2003 | US6534302 22438, 23553, 25278, and 26212 novel human sulfatases |
03/18/2003 | US6534300 Methods for producing highly phosphorylated lysosomal hydrolases |
03/18/2003 | US6534299 Peptide for use in development of human diagnostics and therapeutics; for use in deection and treatment of cancer, inflammation, immune disorders and development defects |
03/18/2003 | US6534298 Nucleic acids encoding α-1,3 fucosyltransferases and expression systems for making and expressing them |
03/18/2003 | US6534297 Recombinantly producing levodione reductase |
03/18/2003 | US6534295 Cell lysis device |
03/18/2003 | US6534288 Precursor of human insulin or insulin analog consisting of optional fusion portion, B chain of human insulin linked by amino acid chain to A chain of human insulin, in which chains can be modified with activity being preserved |
03/18/2003 | US6534286 Protein production in Aureobasidium pullulans |
03/18/2003 | US6534284 Isolated polynucleotide selected from polynucleotide encoding polypeptide having specified amino acid sequence, and polynucleotide fully complementary to that polynucleotide |
03/18/2003 | US6534275 Isolated polypeptide having specified amino acid sequence or immunogenic fragment thereof |
03/18/2003 | US6534101 Enzymes mixture obtained from Penicillium funiculosum |
03/18/2003 | US6534061 Isolated DNA98853 and DNA101848 polypeptides |
03/18/2003 | US6534054 Probiotic/therapeutic uses of nonpathogenic probiobiotic microorganisms; manufacturing the formulation from the plant derived material |
03/18/2003 | US6534053 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
03/18/2003 | CA2252004C Culture medium for revealing enterohaemorragic e. coli bacteria and procedure therefor |
03/18/2003 | CA2045175C Production of proteins using homologous recombination |
03/17/2003 | WO2002022833A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug |
03/17/2003 | CA2422759A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug |
03/17/2003 | CA2403157A1 Dna encoding the baboon and cynomolgus macaque prostaglandin e2 receptor ep4 subtype |
03/17/2003 | CA2403058A1 Dna encoding the chimpanzee prostaglandin e2 receptor ep4 subtype |
03/13/2003 | WO2003021273A2 Diagnosis of carcinomas |
03/13/2003 | WO2003021265A1 Genetic construct intracellular monitoring system |
03/13/2003 | WO2003020985A1 Detection of genetic sequences using a bipartite probe |
03/13/2003 | WO2003020959A1 Products containing quantum of bioparticles and method for production thereof |
03/13/2003 | WO2003020934A1 Compositions and methods relating to colon specific genes and proteins |
03/13/2003 | WO2003020929A1 Novel amide hydrolase gene |
03/13/2003 | WO2003020928A2 Identification of eukaryotic internal ribosome entry site (ires) elements |
03/13/2003 | WO2003020927A2 Creation of artificial internal ribosome entry site (ires) elements |
03/13/2003 | WO2003020918A1 Mediucm for detecting vana and vanb vancomycin-resistant enterococci and method of using the same |
03/13/2003 | WO2003020917A1 Improved methods for producing oocysts |
03/13/2003 | WO2003020916A2 Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof |
03/13/2003 | WO2003020897A2 Compositions and methods relating to ovary specific genes and proteins |
03/13/2003 | WO2003020890A2 Genes encoding baeyer-villiger monooxygenases |
03/13/2003 | WO2003020885A2 Identification of sortase gene |
03/13/2003 | WO2003020876A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
03/13/2003 | WO2003020763A2 Soluble t cell receptor |
03/13/2003 | WO2003020759A2 A caspase- 8 binding protein, its preparation and use |
03/13/2003 | WO2003020757A2 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation |
03/13/2003 | WO2003020746A1 Modified transferrin fusion proteins |
03/13/2003 | WO2003020111A2 Alternatively spliced circulating tissue factor |
03/13/2003 | WO2002097050A3 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
03/13/2003 | WO2002095055A8 Compositions and methods for use in isolation of nucleic acid molecules |
03/13/2003 | WO2002095006A3 Muscle-specific expression vectors |
03/13/2003 | WO2002092757A3 Enzyme over-producing transgenic microorganisms |
03/13/2003 | WO2002077217A3 Human dual specificity protein phosphatase 7-like protein |
03/13/2003 | WO2002077213A3 New elongase gene and production of δ9-polyunsaturated fatty acids |
03/13/2003 | WO2002074942A3 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics |
03/13/2003 | WO2002072777A3 A novel antagonistic yeast useful in controlling spoilage of agricultural produce, methods of use thereof and compositions containing same |
03/13/2003 | WO2002072634A3 Recombinant proteinase k |
03/13/2003 | WO2002070713A3 Dna sequence from kluyveromyces marxianus comprising regulatory regions for expressing proteins |
03/13/2003 | WO2002070682A3 Methods and compositions for waste treatment |
03/13/2003 | WO2002070666A3 Compositions and methods for regulating autolytic processes in bacteria |
03/13/2003 | WO2002064629A3 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof |
03/13/2003 | WO2002063012A3 Ragweed allergens |
03/13/2003 | WO2002061106A3 Method for producing cysteine, cystine and glutathione by fermentation |
03/13/2003 | WO2002061038A3 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples |
03/13/2003 | WO2002053180A3 Immunizing compositions and methods of use |
03/13/2003 | WO2002050286A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
03/13/2003 | WO2002048363A3 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
03/13/2003 | WO2002046407A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
03/13/2003 | WO2002046369A3 Yeast-based assays involving gpcrs |
03/13/2003 | WO2002044380A3 Master bone formation transcription factor: compositions and methods of use |
03/13/2003 | WO2002044379A3 Transforming growth factor-beta-related molecules and uses thereof |
03/13/2003 | WO2002044364A3 Polypeptides involved in immune response |
03/13/2003 | WO2002044350A3 Cyclodextrin glucanotransferase (cgtase), obtained from bacillus agaradherens (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase |
03/13/2003 | WO2002042471A3 Methods and materials for the synthesis of organic products |
03/13/2003 | WO2002042466A3 Nucleotide sequences coding for the cysq gene |
03/13/2003 | WO2002042456A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
03/13/2003 | WO2002040697A3 Metabolic rate shifts in fermentations expressing recombinant proteins |
03/13/2003 | WO2002040660A3 Promoter for the functional characterisation of g-protein coupled receptors in the yeast saccharomyces cerevisiae |
03/13/2003 | WO2002036773A3 Nod2 nucleic acids and proteins |
03/13/2003 | WO2002036745A3 Process for producing freeze dried competent cells and use thereof in cloning |
03/13/2003 | WO2002034773A3 Streptococcal genes |
03/13/2003 | WO2002034288A3 Vaccine for treating allergy |
03/13/2003 | WO2002031177A3 Method for synthesising peptides, peptide mimetics and proteins |
03/13/2003 | WO2002029019A3 2.5-diketo-d-gluconic acid reductases and methods of use |
03/13/2003 | WO2002026822A3 Pumpcn compositions and uses thereof |
03/13/2003 | WO2002024920A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |